Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
US11424006B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2018 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Aug 14, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B15/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.